<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Olsson B</submitter><funding>European Research Council</funding><pagination>41-49</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8743336</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>63(1)</volume><pubmed_abstract>In an open-label, controlled study of nitisinone in alkaptonuria (SONIA 2), patients were advised to lower dietary protein intake to reduce serum tyrosine (s-Tyr) levels and the risk of keratopathy. A body weight increase was observed in the nitisinone-treated patients but not in the control group. To investigate the effectiveness and consequence of protein restriction in patients with alkaptonuria, a post-hoc analysis of SONIA 2 was performed. One hundred and thirty-eight patients were randomised (nitisinone: n = 69, controls: n = 69). Comparison of baseline and Month 12 data on 24-h urinary excretion of HGA (u-HGA&lt;sub>24&lt;/sub>) and urea (u-urea&lt;sub>24&lt;/sub>, used as an approximate protein intake measure), tyrosine and body weight were performed using paired &lt;i>t&lt;/i> tests. Comparisons of</pubmed_abstract><journal>JIMD reports</journal><pubmed_title>Effects of a protein-restricted diet on body weight and serum tyrosine concentrations in patients with alkaptonuria.</pubmed_title><pmcid>PMC8743336</pmcid><funding_grant_id>304985</funding_grant_id><pubmed_authors>Milan A</pubmed_authors><pubmed_authors>Arnoux JB</pubmed_authors><pubmed_authors>Ranganath L</pubmed_authors><pubmed_authors>Imrich R</pubmed_authors><pubmed_authors>Rudebeck M</pubmed_authors><pubmed_authors>Olsson B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of a protein-restricted diet on body weight and serum tyrosine concentrations in patients with alkaptonuria.</name><description>In an open-label, controlled study of nitisinone in alkaptonuria (SONIA 2), patients were advised to lower dietary protein intake to reduce serum tyrosine (s-Tyr) levels and the risk of keratopathy. A body weight increase was observed in the nitisinone-treated patients but not in the control group. To investigate the effectiveness and consequence of protein restriction in patients with alkaptonuria, a post-hoc analysis of SONIA 2 was performed. One hundred and thirty-eight patients were randomised (nitisinone: n = 69, controls: n = 69). Comparison of baseline and Month 12 data on 24-h urinary excretion of HGA (u-HGA&lt;sub>24&lt;/sub>) and urea (u-urea&lt;sub>24&lt;/sub>, used as an approximate protein intake measure), tyrosine and body weight were performed using paired &lt;i>t&lt;/i> tests. Comparisons of</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2026-05-07T20:18:44.898Z</modification><creation>2022-02-11T16:17:00.053Z</creation></dates><accession>S-EPMC8743336</accession><cross_references><pubmed>35028270</pubmed><doi>10.1002/jmd2.12255</doi></cross_references></HashMap>